Biomarkers /

CTNNBL1

Back to Biomarkers List
Associated Diseases

Overview

Location [1]
20q11.23
Protein [2]
Beta-catenin-like protein 1
Synonyms [1]
NAP, C20orf33, dJ633O20.1, PP8304, P14L

CTNNBL1 is altered in 0.04% of all cancers with lung adenocarcinoma, dendritic cell tumor, not otherwise specified, esophageal adenocarcinoma, gastric adenocarcinoma, and glioblastoma having the greatest prevalence of alterations [3].

CTNNBL1 GENIE Cases - Top Diseases

The most common alterations in CTNNBL1 are CTNNBL1-RAF1 Fusion (0.04%) and CTNNBL1-NOTCH2 Fusion (0.01%) [3].

CTNNBL1 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.